CAS Medical Systems is a leading developer and manufacturer of medical devices for non-invasive patient monitoring. The company's FORE-SIGHT Absolute Cerebral Oximeter provides a highly accurate, non-invasive, continuous measurement of absolute cerebral tissue oxygen saturation. This is a superior tool to alert doctors to dangerously low levels of oxygen in the brain and other important tissues.
The company announced today the promotion of John Gamelin Ph.D. to vice-president of research and development for CAS Medical. Dr. Gamelin has been with the company since 2009 and most recently served as director of research and development. He has been responsible for driving the three major development programs that will deliver new products in each of the company's core markets within the next year.
Dr. Gamelin has more than 20 years of experience inventing and developing optical, acoustic, and electronic instrumentation - from research concept to commercial production. Prior to joining CAS Medical, he served as research assistant professor at the University of Connecticut in its Biomedical Engineering program. While there, Dr. Gamelin conducted research on novel optical, ultrasound, and radiation imaging modalities for cancer detection and diagnostics.
He was also a co-founder and vice-president of engineering for Tellium, an optical switching company. It moved from start-up status to generating over $100 million in revenues in just four years. Dr. Gamelin also holds four U.S. patents in optical cross-connects and switching technologies and several patent applications in biomedical imaging and laser transmitters.
For additional information about CAS Medical Systems and its entire product line, please visit www.casmed.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html